Arch Venture Management’s Unity Biotechnology UBX Stock Holding History

Arch Venture Management’s Portfolio UBX Stock Details UBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,004,817	Closed	-$386K	–	10
2025 Q2	$386K	Hold	1,004,817	–	–	0.13%	10
2025 Q1	$1.05M	Hold	1,004,817	–	–	0.51%	7
2024 Q4	$981K	Hold	1,004,817	–	–	0.43%	8
2024 Q3	$1.48M	Hold	1,004,817	–	–	0.57%	8
2024 Q2	$1.36M	Hold	1,004,817	–	–	0.51%	7
2024 Q1	$1.65M	Hold	1,004,817	–	–	2.05%	8
2023 Q4	$1.94M	Hold	1,004,817	–	–	1.19%	6
2023 Q3	$2.41M	Hold	1,004,817	–	–	1.57%	6
2023 Q2	$2.56M	Hold	1,004,817	–	–	1.58%	6
2023 Q1	$1.64M	Hold	1,004,817	–	–	0.79%	8
2022 Q4	$2.75M	Sell	1,004,817 -1	-0%	-$3	0.71%	7
2022 Q3	$3.97M	Buy	+1,004,818	New	+$6.34M	0.51%	8

Other funds holding UBX

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return